Saskatchewan Premier Scott Moe said he would not order any lockdowns or public health measures that would close businesses to curb the spread of COVID-19 because he does not think it is fair to restrict people’s activities.
The Oct. 25 announcement came as COVID-19 hospitalizations are pushing the province’s intensive care capacity to the limit.
This month, Saskatchewan had more intensive care patients per capita than any other province at any point in the pandemic. Without additional public health measures, provincial modelling showed that there could be more than 200 COVID-19 patients in intensive care by Jan. 1 – more than double capacity.
The Saskatchewan Health Authority warned Moe’s government about the risk of a fall surge in hospitalizations in June, and trends in admissions have closely tracked those predictions. Even so, the province lifted pandemic measures in July and didn’t reinstate any precautions until mid-September, when the government reintroduced a mask mandate and announced a proof-of-vaccination program.
On Twitter, Canadian Medical Association President Dr. Katharine Smart decried Moe’s inaction and “continued attempts at gaslighting.” In a previous statement, Smart called on Saskatchewan’s government to reinstate strict public health measures, including circuit breaker lockdowns, noting that further delays are “simply not acceptable.”
In the meantime, Saskatchewan continues to transfer patients to Ontario and will receive six critical care nurses from the military this week. The Saskatchewan Health Authority is also hiring 32 critical care nurses and training 39 nursing students to work in intensive care.
In other COVID-19 news:
- Vaccination against SARS-CoV-2 does not increase the risk of miscarriage in early pregnancy, according to research in the New England Journal of Medicine. Researchers analyzed data on first-trimester pregnancies in Norway and compared people who miscarried versus those who did not and whether they were more likely to have recently received a COVID-19 vaccine. Accounting for underlying health conditions and other patient characteristics, they found no correlation between vaccination and miscarriage.
- Infection with SARS-CoV-2 poses a greater risk of rare neurological conditions than vaccination against the virus, according to a University of Oxford study published in Nature Medicine. Researchers looked at the health records of 32 million people in England to analyze the risk of developing Bell’s palsy, Guillain-Barré syndrome and other rare conditions after testing positive for SARS-CoV-2 versus receiving Pfizer or AstraZeneca’s COVID-19 vaccines. Although vaccination against SARS-CoV-2 slightly increased the risk of some conditions, infection with the virus posed a substantially higher risk of all neurological complications examined.
- Four physicians are threatening to sue Alberta Health Services (AHS) over a policy requiring workers to be fully vaccinated against COVID-19 by Nov. 30. In their statement of claim, the doctors allege that the policy violates their right to bodily autonomy and breaches their confidentiality because a worker’s vaccine status will be evident if they have to go on leave. Such lawsuits are unlikely to be successful, according to University of Calgary law professor Lorian Hardcastle. “The allegations… are quite confusing because, of course, nobody is forcing treatment on anyone.” So far, 94% of AHS employees and physicians are fully vaccinated.
- Quebec may again postpone its deadline for healthcare workers to be fully vaccinated against SARS-CoV-2. Previously, the province extended the original Oct. 15 deadline to Nov. 15 because of concerns about staffing shortages. Premier François Legault said a further extension may be necessary for the same reason. More than 19,600 healthcare workers in Quebec are not fully vaccinated. The province is seeking to recruit 4,000 nurses to the public health system, including by offering up to $18,000 in bonuses.
- Alberta has asked the federal government for a supply of the Johnson & Johnson COVID-19 vaccine, but there is still no timeline on when the doses will become available. Provincial officials hope that offering the single-shot, viral vector vaccine as an alternative to available mRNA shots will improve immunization rates in some areas of rural Alberta. Premier Jason Kenney said he has heard from people who are hesitant to get an mRNA vaccine but would consider receiving the Johnson & Johnson shot.
- Moderna said a half-dose of its COVID-19 vaccine is safe and effective in children aged 6-11, according to a study of 4,753 children. The most common side effects in young children, like in adults, included fatigue, headache, fever and injection-site pain. The study was too small to pick up any extremely rare side effects. Moderna plans to submit the data to the United States Food and Drug Administration and other regulators soon. Health Canada approved the company’s COVID-19 vaccine for teens aged 12-17 at the end of August.
- The pharmaceutical company Merck is seeking authorization from the European Medicines Agency for its COVID-19 antiviral treatment The company submitted an approval request to the U.S. Food and Drug Administration earlier this month. If approved, the pill would be the first treatment for COVID-19 not administered intravenously or through needles. Merck has reported that the treatment reduces hospitalizations and deaths by half in patients with early COVID-19 symptoms.
Photo credit: iStock.com/JazzIRT